Adjuvant chemotherapy for early breast cancer.
作者信息
Smith I E
出版信息
Br Med J (Clin Res Ed). 1983 Aug 6;287(6389):379-80. doi: 10.1136/bmj.287.6389.379.
Abstract
摘要
相似文献
1
Adjuvant chemotherapy for early breast cancer.早期乳腺癌的辅助化疗。
Br Med J (Clin Res Ed). 1983 Aug 6;287(6389):379-80. doi: 10.1136/bmj.287.6389.379.
2
A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
Recent Results Cancer Res. 1984;96:74-89. doi: 10.1007/978-3-642-82357-2_10.
3
Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
Recent Results Cancer Res. 1984;96:166-74. doi: 10.1007/978-3-642-82357-2_20.
4
Adjuvant chemotherapy for breast cancer. Implications of clinical trials.
Postgrad Med. 1985 Jan;77(1):75-7, 80-3. doi: 10.1080/00325481.1985.11698840.
5
[Sequential combination chemotherapy in metastatic cancer of the breast].[转移性乳腺癌的序贯联合化疗]
Medicina (B Aires). 1984;44(1):15-22.
6
Adjuvant systemic therapy in primary breast cancer.原发性乳腺癌的辅助性全身治疗。
Acta Chir Scand Suppl. 1984;519:43-53.
7
Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.环磷酰胺、甲氨蝶呤、5-氟尿嘧啶、长春新碱和泼尼松辅助化疗与单药左旋苯丙氨酸氮芥治疗可手术乳腺癌且腋窝淋巴结阳性患者的比较：西南肿瘤协作组20年研究结果
Cancer. 2003 Jan 1;97(1):21-9. doi: 10.1002/cncr.10982.
8
[Adjuvant chemotherapy in premenopausal women].
Tidsskr Nor Laegeforen. 1991 Sep 30;111(23):2857-8.
9
The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival.
Cancer Treat Rep. 1983 Jun;67(6):519-26.
10
Favorable factors in the adjuvant therapy of breast cancer.乳腺癌辅助治疗中的有利因素。
Cancer. 1982 Jul 1;50(1):18-23. doi: 10.1002/1097-0142(19820701)50:1<18::aid-cncr2820500105>3.0.co;2-j.
本文引用的文献
1
Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy.乳房切除术后辅助化疗相关的精神疾病发病率和身体毒性。
Br Med J. 1980 Nov 1;281(6249):1179-80. doi: 10.1136/bmj.281.6249.1179.
2
Significance of relapse after adjuvant treatment with combination chemotherapy or 5-fluorouracil alone in high-risk breast cancer. A Western Cancer Study Group Project.
Cancer Res. 1981 Nov;41(11 Pt 1):4399-403.
3
The social, emotional and financial implications of adjuvant chemotherapy in breast cancer.辅助化疗对乳腺癌的社会、情感和经济影响。
Br J Surg. 1981 Apr;68(4):261-4. doi: 10.1002/bjs.1800680413.
4
Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma.
Cancer Treat Rep. 1982 Aug;66(8):1601-4.
5
Adjuvant treatment of node-positive breast cancer with adriamycin-cyclophosphamide with or without radiation therapy: interim results of an ongoing clinical trial.用阿霉素-环磷酰胺辅助治疗淋巴结阳性乳腺癌，加或不加放射治疗：一项正在进行的临床试验的中期结果。
Recent Results Cancer Res. 1982;80:162-9. doi: 10.1007/978-3-642-81685-7_27.
6
Adjuvant chemotherapy in breast cancer.乳腺癌辅助化疗
Recent Results Cancer Res. 1982;80:142-8. doi: 10.1007/978-3-642-81685-7_24.
7
Adjuvant chemotherapy for breast cancer: side effects and quality of life.乳腺癌辅助化疗：副作用与生活质量
Br Med J. 1980 Dec 13;281(6255):1594-7. doi: 10.1136/bmj.281.6255.1594.
8
Pathologic findings from the National Surgical Adjuvant Breast Project. VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation.
Cancer. 1983 Jan 15;51(2):181-91. doi: 10.1002/1097-0142(19830115)51:2<181::aid-cncr2820510202>3.0.co;2-a.
9
Multimodal treatment in operable breast cancer: five-year results of the CMF programme.可手术乳腺癌的多模式治疗：CMF方案的五年结果
Br Med J (Clin Res Ed). 1981 May 2;282(6274):1427-31. doi: 10.1136/bmj.282.6274.1427.
10
Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients.辅助化学激素疗法对乳腺癌患者卵巢和肾上腺功能的影响。
Cancer Res. 1980 Nov;40(11):4043-7.
Zotero 插件